Suven Life Sciences Ltd vs Vijaya Diagnostic Centre Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Suven Life Sciences Ltd is ₹ 261.8 as of 23 Oct 15:30 . The P/E Ratio of Suven Life Sciences Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Vijaya Diagnostic Centre Ltd changed from 40.7 on March 2022 to 51.3 on March 2026 . This represents a CAGR of 4.74% over 5 years The Market Cap of Suven Life Sciences Ltd changed from ₹ 896.07 crore on March 2021 to ₹ 3503 crore on March 2026 . This represents a CAGR of 25.51% over 6 yearsThe Market Cap of Vijaya Diagnostic Centre Ltd changed from ₹ 4463 crore on March 2022 to ₹ 8864 crore on March 2026 . This represents a CAGR of 14.71% over 5 years The revenue of Suven Life Sciences Ltd for the Jun '26 is ₹ 11.09 crore as compare to the Mar '26 revenue of ₹ 8.3 crore. This represent the growth of 33.61% The revenue of Vijaya Diagnostic Centre Ltd for the Jun '26 is ₹ 239.51 crore as compare to the Mar '26 revenue of ₹ 221.78 crore. This represent the growth of 7.99% The ebitda of Suven Life Sciences Ltd for the Jun '26 is ₹ -124 crore as compare to the Mar '26 ebitda of ₹ -43.86 crore. This represent the growth of 184.95% The ebitda of Vijaya Diagnostic Centre Ltd for the Jun '26 is ₹ 107.07 crore as compare to the Mar '26 ebitda of ₹ 97.92 crore. This represent the growth of 9.34% The net profit of Suven Life Sciences Ltd changed from ₹ -28.04 crore to ₹ -127 crore over 9 quarters. This represents a CAGR of 96.11% The net profit of Vijaya Diagnostic Centre Ltd changed from ₹ 31.51 crore to ₹ 53.1 crore over 9 quarters. This represents a CAGR of 26.10% The Dividend Payout of Suven Life Sciences Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Vijaya Diagnostic Centre Ltd changed from 9.44 % on March 2022 to 11.54 % on March 2026 . This represents a CAGR of 4.10% over 5 years .

About Suven Life Sciences Ltd

Suven Life Sciences Limited, formerly known as Suven Pharmaceuticals Limited was incorporated in March, 1989.
The Company changed its name from Suven Pharmaceuticals Limited to Suven Life Sciences Limited in September, 2003.
Promoted by Venkateswarlu Jasti, Company began its operations in 1989 as specialty chemicals provider. The Company is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of novel therapeutics for the treatment of neurodegenerative disorders.
Suven has a wholly owned subsidiary, Suven Neurosciences, Inc., USA, focused on clinical development activities of Suven molecules from phase 2, Proof-of-Concept (POC) studies. The Company is in the business of Contract Research And Manufacturing Services (CRAMS), catering to the needs of global life science industry and fine chemical majors.

About Vijaya Diagnostic Centre Ltd

Vijaya Diagnostic Centre Limited established in 1981, is a leading provider of diagnostic services in India.
With a steadfast commitment to delivering high quality, comprehensive diagnostic solutions, Vijaya has grown into the largest integrated diagnostic chain in Southern India.
Founded by Dr. S. Surendranath Reddy, the journey began to offer reliable and comprehensive diagnostic services under one roof.
Today, Company operate a vast network of 151+ diagnostic centres across 25+ cities, including Telangana, Andhra Pradesh, Maharashtra, Karnataka, West Bengal and the National Capital Region. Their state-of-the-art facilities are equipped with the latest technology, to offer a wide range of pathology and radiology services.
Company provides Corporate Wellness solutions.

FAQs for the comparison of Suven Life Sciences Ltd and Vijaya Diagnostic Centre Ltd

Which company has a larger market capitalization, Suven Life Sciences Ltd or Vijaya Diagnostic Centre Ltd?

Market cap of Suven Life Sciences Ltd is 7,397 Cr while Market cap of Vijaya Diagnostic Centre Ltd is 14,296 Cr

What are the key factors driving the stock performance of Suven Life Sciences Ltd and Vijaya Diagnostic Centre Ltd?

The stock performance of Suven Life Sciences Ltd and Vijaya Diagnostic Centre Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Suven Life Sciences Ltd and Vijaya Diagnostic Centre Ltd?

As of October 25, 2026, the Suven Life Sciences Ltd stock price is INR ₹261.8. On the other hand, Vijaya Diagnostic Centre Ltd stock price is INR ₹1388.05.

How do dividend payouts of Suven Life Sciences Ltd and Vijaya Diagnostic Centre Ltd compare?

To compare the dividend payouts of Suven Life Sciences Ltd and Vijaya Diagnostic Centre Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.